November 29, 2018

E. Claiborne Robins Company, Inc. v. Teva Pharmaceutical Industries, LTD.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. September 28, 2020

    Teva Fails To Get $110M Drug Contract Suit Tossed

    Teva is unable to dodge a $110 million case claiming that it botched the marketing and sale of the muscle relaxant Amrix, after a Virginia federal judge found the suit at this point had sufficient allegations that Teva and its affiliates breached a contract.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS